3D QSAR-based design and liquid phase combinatorial synthesis of 1,2-disubstituted benzimidazole-5-carboxylic acid and 3-substituted-5H-benzimidazo[1,2-d][1,4]benzodiazepin-6(7H)-one derivatives as anti-mycobacterial agents-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

3D QSAR-based design and liquid phase combinatorial synthesis of 1,2-disubstituted benzimidazole-5-carboxylic acid and 3-substituted-5H-benzimidazo[1,2-d][1,4]benzodiazepin-6(7H)-one derivatives as anti-mycobacterial agents

Published:2019 Issue:5 Volume:10 Page:817-827
ISSN:2040-2503
Container-title:MedChemComm
language:en
Short-container-title:Med. Chem. Commun.

Author:

Sitwala Nikum D.¹²³⁴,Vyas Vivek K.¹²³⁴,Gedia Piyush¹²³⁴,Patel Kinjal¹²³⁴,Bouzeyen Rania⁵⁶⁷⁸⁶,Kidwai Saqib⁹¹⁰¹¹⁴,Singh Ramandeep⁹¹⁰¹¹⁴,Ghate Manjunath D.¹²³⁴^ORCID

Affiliation:

1. Department of Pharmaceutical Chemistry, Institute of Pharmacy

2. Nirma University

3. Ahmedabad 382481

4. India

5. Institut Pasteur de Tunis

6. Tunis

7. Tunisia

8. Université Tunis El Manar

9. Tuberculosis Research Laboratory

10. Vaccine and Infectious Disease Research Centre

11. Translational Health Science and Technology Institute

Abstract

Novel benzimidazole-5-carboxylic acid and benzodiazepin-6(7H)-one derivatives as anti-mycobacterial agents.

Funder

Science and Engineering Research Board

Department of Biotechnology , Ministry of Science and Technology

Department of Science and Technology, Government of Kerala

Publisher

Royal Society of Chemistry (RSC)

Subject

Pharmaceutical Science,Biochemistry,Drug Discovery,Molecular Medicine,Pharmacology,Organic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2019/MD/C9MD00006B

Reference36 articles.

1. The challenge of new drug discovery for tuberculosis

2. WHO, (accessed April 2018)

3. Overview of drug-resistant tuberculosis worldwide

4. Advances in the development of new tuberculosis drugs and treatment regimens

5. Tuberculosis eradication versus control

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-silico investigation and drug likeliness studies of benzimidazole congeners: The new face of innovation;Informatics in Medicine Unlocked;2023

2. Discovery of newer pyrazole derivatives with potential anti-tubercular activity via 3D-QSAR based pharmacophore modelling, virtual screening, molecular docking and molecular dynamics simulation studies;Molecular Diversity;2022-08-15

3. Microwave-Assisted Copper(II)-Catalyzed Cascade Cyclization of 2-Propargylamino/Oxy-Arylaldehydes and O-Phenylenediamines: Access to Densely Functionalized Benzo[f]Imidazo[1,2-d][1,4]Oxazepines and Benzo[f]Imidazo[1,2-d][1,4]Diazepines;The Journal of Organic Chemistry;2022-06-28

4. Recent advancement in drug development of nitro( NO ₂ )‐heterocyclic compounds as lead scaffolds for the treatment of Mycobacterium tuberculosis;Drug Development Research;2022-02

5. Recent advancements and developments in search of anti-tuberculosis agents: A quinquennial update and future directions;Journal of Molecular Structure;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3